• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种有力的预测卵巢反应的标志物的机器智能,以定制辅助生殖技术。

Machine-intelligence for developing a potent signature to predict ovarian response to tailor assisted reproduction technology.

机构信息

Reproductive Medical Center, Renmin Hospital of Wuhan University and Hubei Clinic Research Center for Assisted Reproductive Technology and Embryonic Development, Wuhan 430060, China.

Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan 430060, China.

出版信息

Aging (Albany NY). 2021 May 17;13(13):17137-17154. doi: 10.18632/aging.203032.

DOI:10.18632/aging.203032
PMID:33999860
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8312467/
Abstract

The prediction of poor ovarian response (POR) for stratified interference is a critical clinical issue that has received an increasing amount of recent concern. Anthropogenic diagnostic modes remain too simple for the handling of actual clinical complexity. Therefore, this study conducted extensive selection using models that were derived from a variety of machine learning algorithms, including random forest (RF), decision trees, eXtreme Gradient Boosting (XGBoost), support vector machine (SVM), and artificial neural networks (ANN) for the development of two models called the COS pre-launch model (CPLM) and the hCG pre-trigger model (HPTM) to assess POR based on different requirements. The results demonstrated that CPLM constructed using ANN achieved the highest AUC result of all the algorithms in COS pre-launch (AUC=0.859, C-index=0.87, good calibration), and HPTL constructed using random forest was found to be the most effective in hCG pre-trigger (AUC=0.903, C-index=0.90, good calibration). It is notable that CPLM and HPTM exhibited better performance than common clinical characteristics (0.895 [CPLM], and 0.903 [HPTM] in comparison to 0.824 [anti-Müllerian hormone (AMH)], and 0.799 [antral follicle count (AFC)]). Furthermore, variable importance figure elucidated the values of AMH, AFC, and E level and follicle number on hCG day, which provides important theoretical guidance and experimental data for further application. Generally, the CPLM and HPTM can offer effective POR prediction for patients who are receiving assisted reproduction technology (ART), and has great potential for guiding the clinical treatment of infertility.

摘要

预测卵巢低反应(POR)对于分层干预是一个关键的临床问题,最近受到了越来越多的关注。人为的诊断模式对于处理实际的临床复杂性来说仍然过于简单。因此,本研究使用了各种机器学习算法(包括随机森林(RF)、决策树、极端梯度提升(XGBoost)、支持向量机(SVM)和人工神经网络(ANN))进行了广泛的选择,为两种模型开发了两种模型,称为 COS 预启动模型(CPLM)和 hCG 预触发模型(HPTM),根据不同的需求评估 POR。结果表明,基于 ANN 构建的 CPLM 在 COS 预启动时实现了所有算法中最高的 AUC 结果(AUC=0.859,C 指数=0.87,良好校准),而基于随机森林构建的 HPTL 在 hCG 预触发时是最有效的(AUC=0.903,C 指数=0.90,良好校准)。值得注意的是,CPLM 和 HPTM 的表现优于常见的临床特征(CPLM 为 0.895,HPTM 为 0.903,而抗苗勒管激素(AMH)为 0.824,窦卵泡计数(AFC)为 0.799)。此外,变量重要性图阐明了 AMH、AFC 和 E 水平以及 hCG 日的卵泡数的重要性,为进一步应用提供了重要的理论指导和实验数据。一般来说,CPLM 和 HPTM 可以为接受辅助生殖技术(ART)的患者提供有效的 POR 预测,具有指导不孕临床治疗的巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3779/8312467/cd6deb546b7f/aging-13-203032-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3779/8312467/2d027ab8ff28/aging-13-203032-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3779/8312467/1144c52ca64c/aging-13-203032-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3779/8312467/a88d59860e34/aging-13-203032-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3779/8312467/3e715c8f45d9/aging-13-203032-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3779/8312467/cd6deb546b7f/aging-13-203032-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3779/8312467/2d027ab8ff28/aging-13-203032-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3779/8312467/1144c52ca64c/aging-13-203032-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3779/8312467/a88d59860e34/aging-13-203032-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3779/8312467/3e715c8f45d9/aging-13-203032-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3779/8312467/cd6deb546b7f/aging-13-203032-g005.jpg

相似文献

1
Machine-intelligence for developing a potent signature to predict ovarian response to tailor assisted reproduction technology.开发一种有力的预测卵巢反应的标志物的机器智能,以定制辅助生殖技术。
Aging (Albany NY). 2021 May 17;13(13):17137-17154. doi: 10.18632/aging.203032.
2
Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.抗苗勒管激素比抑制素 B、卵泡刺激素、雌二醇或窦卵泡计数在预测体外受精结局方面更有价值。
Arch Gynecol Obstet. 2011 Jun;283(6):1415-21. doi: 10.1007/s00404-011-1889-7. Epub 2011 Mar 29.
3
A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.前瞻性、对照分析抗苗勒管激素、抑制素 B 和三维超声卵巢储备决定因素在预测控制性卵巢刺激反应不良中的作用。
Fertil Steril. 2010 Feb;93(3):855-64. doi: 10.1016/j.fertnstert.2008.10.042. Epub 2008 Nov 30.
4
Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.与年龄相同、无不孕史的女性相比,40 岁以下的不孕女性的抗苗勒氏管激素水平和窦卵泡计数相似。
Hum Reprod. 2016 May;31(5):1034-45. doi: 10.1093/humrep/dew032. Epub 2016 Mar 9.
5
Predictive values of anti-müllerian hormone, antral follicle count and ovarian response prediction index (ORPI) for assisted reproductive technology outcomes.抗苗勒管激素、窦卵泡计数及卵巢反应预测指数(ORPI)对辅助生殖技术结局的预测价值。
J Obstet Gynaecol. 2017 Jan;37(1):82-88. doi: 10.1080/01443615.2016.1225025. Epub 2016 Dec 15.
6
Assessment and quantification of ovarian reserve on the basis of machine learning models.基于机器学习模型的卵巢储备评估和量化。
Front Endocrinol (Lausanne). 2023 Mar 15;14:1087429. doi: 10.3389/fendo.2023.1087429. eCollection 2023.
7
Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response.抗苗勒管激素和窦卵泡计数作为卵巢反应生物标志物的技术和性能特征。
Hum Reprod Update. 2015 Nov-Dec;21(6):698-710. doi: 10.1093/humupd/dmu062. Epub 2014 Dec 8.
8
Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.抗苗勒管激素与窦卵泡计数用于定义 FSH 的起始剂量。
Reprod Biomed Online. 2013 Oct;27(4):390-9. doi: 10.1016/j.rbmo.2013.07.008. Epub 2013 Jul 23.
9
Application of Artificial Intelligence for Preoperative Diagnostic and Prognostic Prediction in Epithelial Ovarian Cancer Based on Blood Biomarkers.基于血液生物标志物的人工智能在卵巢上皮性癌术前诊断和预后预测中的应用。
Clin Cancer Res. 2019 May 15;25(10):3006-3015. doi: 10.1158/1078-0432.CCR-18-3378. Epub 2019 Apr 11.
10
Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.口服避孕药使用者的卵巢储备评估,以寻求对其生殖寿命的生育建议。
Hum Reprod. 2015 Oct;30(10):2364-75. doi: 10.1093/humrep/dev197. Epub 2015 Aug 25.

引用本文的文献

1
A retrospective study: establishment and validation of the prediction model for the gonadotropin starting dose in IVF/ICSI-ET among normal ovarian response women.一项回顾性研究:正常卵巢反应女性体外受精/卵胞浆内单精子注射-胚胎移植中促性腺激素起始剂量预测模型的建立与验证
Front Endocrinol (Lausanne). 2025 Jun 23;16:1600936. doi: 10.3389/fendo.2025.1600936. eCollection 2025.
2
The Role of Artificial Intelligence in Female Infertility Diagnosis: An Update.人工智能在女性不孕症诊断中的作用:最新进展
J Clin Med. 2025 Apr 30;14(9):3127. doi: 10.3390/jcm14093127.
3
Pharmacogenetic analysis using artificial intelligence (AI) to identify polymorphisms associated with sub-optimal ovarian response and hyper-response.

本文引用的文献

1
Ovarian biomarkers predict controlled ovarian stimulation for in vitro fertilisation treatment in Singapore.卵巢生物标志物可预测新加坡体外受精治疗中的控制性卵巢刺激。
Singapore Med J. 2020 Sep;61(9):463-468. doi: 10.11622/smedj.2020130.
2
Early ovarian ageing: is a low number of oocytes harvested in young women associated with an earlier and increased risk of age-related diseases?卵巢早衰:年轻女性采卵数量少是否与与年龄相关疾病的发生更早和风险增加有关?
Hum Reprod. 2020 Oct 1;35(10):2375-2390. doi: 10.1093/humrep/deaa188.
3
Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function.
利用人工智能进行药物遗传学分析,以识别与卵巢反应欠佳和过度反应相关的多态性。
J Assist Reprod Genet. 2025 Apr 2. doi: 10.1007/s10815-025-03471-z.
4
Exploration of the mechanism and therapy of ovarian aging by targeting cellular senescence.通过靶向细胞衰老探索卵巢衰老的机制及治疗方法。
Life Med. 2025 Jan 23;4(1):lnaf004. doi: 10.1093/lifemedi/lnaf004. eCollection 2025 Feb.
5
Harnessing Artificial Intelligence to Predict Ovarian Stimulation Outcomes in In Vitro Fertilization: Scoping Review.利用人工智能预测体外受精中卵巢刺激的结果:范围综述。
J Med Internet Res. 2024 Jul 5;26:e53396. doi: 10.2196/53396.
6
Machine learning-enhanced insights into sphingolipid-based prognostication: revealing the immunological landscape and predictive proficiency for immunomotherapy and chemotherapy responses in pancreatic carcinoma.机器学习增强对基于鞘脂的预后分析的见解:揭示胰腺癌免疫治疗和化疗反应的免疫格局及预测能力。
Front Mol Biosci. 2023 Oct 31;10:1284623. doi: 10.3389/fmolb.2023.1284623. eCollection 2023.
7
Unveiling the role of regulatory T cells in the tumor microenvironment of pancreatic cancer through single-cell transcriptomics and experiments.通过单细胞转录组学和实验揭示调节性 T 细胞在胰腺癌肿瘤微环境中的作用。
Front Immunol. 2023 Sep 11;14:1242909. doi: 10.3389/fimmu.2023.1242909. eCollection 2023.
8
Revealing the role of regulatory T cells in the tumor microenvironment of lung adenocarcinoma: a novel prognostic and immunotherapeutic signature.揭示调节性 T 细胞在肺腺癌肿瘤微环境中的作用:一种新的预后和免疫治疗标志物。
Front Immunol. 2023 Aug 21;14:1244144. doi: 10.3389/fimmu.2023.1244144. eCollection 2023.
9
GADD45B regulates the carcinogenesis process of chronic atrophic gastritis and the metabolic pathways of gastric cancer.GADD45B 调控慢性萎缩性胃炎的癌变过程和胃癌的代谢途径。
Front Endocrinol (Lausanne). 2023 Aug 7;14:1224832. doi: 10.3389/fendo.2023.1224832. eCollection 2023.
10
Tailored machine learning for evaluating the long-term diabetes risk in older individuals: findings from the Irish Longitudinal Study on Ageing (TILDA).个体化机器学习评估老年人长期糖尿病风险:爱尔兰老龄化纵向研究(TILDA)的结果。
BMJ Open. 2023 May 30;13(5):e072991. doi: 10.1136/bmjopen-2023-072991.
抗苗勒管激素与卵巢储备:评估卵巢功能的最新进展。
J Clin Endocrinol Metab. 2020 Nov 1;105(11):3361-73. doi: 10.1210/clinem/dgaa513.
4
A practical perspective on the concordance index for the evaluation and selection of prognostic time-to-event models.关于用于评估和选择预后事件发生时间模型的一致性指数的实用观点。
J Biomed Inform. 2020 Aug;108:103496. doi: 10.1016/j.jbi.2020.103496. Epub 2020 Jul 9.
5
Are ovarian reserve tests reliable in predicting ovarian response? Results from a prospective, cross-sectional, single-center analysis.卵巢储备测试在预测卵巢反应方面可靠吗?一项前瞻性、横断面、单中心分析的结果。
Gynecol Endocrinol. 2021 Apr;37(4):358-366. doi: 10.1080/09513590.2020.1786509. Epub 2020 Jul 2.
6
An introduction to the civil registration and vital statistics systems with applications in low- and middle-income countries.低收入和中等收入国家民事登记与人口动态统计系统介绍及应用
J Health Popul Nutr. 2019 Oct 18;38(Suppl 1):23. doi: 10.1186/s41043-019-0177-1.
7
Ovarian Reserve Markers to Identify Poor Responders in the Context of Poseidon Classification.在波塞冬分类背景下用于识别低反应者的卵巢储备标志物
Front Endocrinol (Lausanne). 2019 May 8;10:281. doi: 10.3389/fendo.2019.00281. eCollection 2019.
8
Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve.双重触发:促性腺激素释放激素激动剂联合人绒毛膜促性腺激素显著提高卵巢储备功能减退患者的活产率。
Reprod Biol Endocrinol. 2019 Jan 4;17(1):7. doi: 10.1186/s12958-018-0451-x.
9
The predictor markers of ovarian response in poor responders under 40 years of age.40岁以下低反应者卵巢反应的预测指标。
Clin Exp Obstet Gynecol. 2016;43(5):650-653.
10
Performance of prognostic modelling of high and low ovarian response to ovarian stimulation for IVF.预测卵巢刺激对 IVF 中卵巢反应高低的预后模型的性能。
Hum Reprod. 2018 Aug 1;33(8):1499-1505. doi: 10.1093/humrep/dey236.